lysophosphatidic acid has been researched along with Cancer-Associated Pain in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Allen, K; Cain, D; Flippen, A; Golovko, MY; Golovko, SA; Johns, M; Juliette, J; Khasabov, SG; Khasabova, IA; Marti, J; Morgan, H; Seybold, VS; Simone, DA; Zhang, W; Zheng, A | 1 |
| Lin, W; Liu, BL; Pan, HL; Zhang, YQ | 1 |
2 other study(ies) available for lysophosphatidic acid and Cancer-Associated Pain
| Article | Year |
|---|---|
Exosome-associated lysophosphatidic acid signaling contributes to cancer pain.
Topics: Animals; Bone Neoplasms; Cancer Pain; Exosomes; Fibrosarcoma; Humans; Lysophospholipids; Mice; Pain | 2023 |
Modulation of Nav1.8 by Lysophosphatidic Acid in the Induction of Bone Cancer Pain.
Topics: Animals; Biophysics; Bone Neoplasms; Cancer Pain; Carcinoma; Disease Models, Animal; Electric Stimulation; Enzyme Inhibitors; Female; Ganglia, Spinal; Gene Expression Regulation, Neoplastic; Hyperalgesia; Isoxazoles; Lysophospholipids; Membrane Potentials; NAV1.8 Voltage-Gated Sodium Channel; Neurons; Pain Measurement; Patch-Clamp Techniques; Propionates; Rats; Rats, Sprague-Dawley; Receptors, Lysophosphatidic Acid | 2016 |